These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34110660)

  • 1. Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection.
    Nguyen LN; Nguyen LNT; Zhao J; Schank M; Dang X; Cao D; Khanal S; Thakuri BKC; Zhang J; Lu Z; Wu XY; El Gazzar M; Ning S; Wang L; Moorman JP; Yao ZQ
    Hepatology; 2021 Nov; 74(5):2380-2394. PubMed ID: 34110660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TRF2 accelerates telomere attrition and DNA damage in naïve CD4 T cells during HCV infection.
    Nguyen LN; Zhao J; Cao D; Dang X; Wang L; Lian J; Zhang Y; Jia Z; Wu XY; Morrison Z; Xie Q; Ji Y; Zhang Z; El Gazzar M; Ning S; Moorman JP; Yao ZQ
    Cell Death Dis; 2018 Sep; 9(9):900. PubMed ID: 30185784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRF2 inhibition rather than telomerase disruption drives CD4T cell dysfunction during chronic viral infection.
    Nguyen LNT; Nguyen LN; Zhao J; Schank M; Dang X; Cao D; Khanal S; Wu XY; Zhang Y; Zhang J; Ning S; Wang L; El Gazzar M; Moorman JP; Yao ZQ
    J Cell Sci; 2022 Jul; 135(13):. PubMed ID: 35660868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
    Zhai N; Li H; Song H; Yang Y; Cui A; Li T; Niu J; Crispe IN; Su L; Tu Z
    PLoS One; 2017; 12(1):e0170516. PubMed ID: 28114346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection.
    Dang X; Ogbu SC; Zhao J; Nguyen LNT; Cao D; Nguyen LN; Khanal S; Schank M; Thakuri BKC; Wu XY; Morrison ZD; Zhang J; Li Z; El Gazzar M; Ning S; Wang L; Wang Z; Moorman JP; Yao ZQ
    Cell Death Dis; 2020 Mar; 11(3):196. PubMed ID: 32193368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shelterin dysfunction promotes CD4+ T cell senescence in Behçet's disease.
    Shi J; Zhang M; Zhang L; Yu X; Sun L; Liu J; Zhao Y; Zheng W
    Rheumatology (Oxford); 2024 Oct; 63(10):2819-2827. PubMed ID: 38145496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcusone C induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
    Wang M; Cao J; Zhu JY; Qiu J; Zhang Y; Shu B; Ou TM; Tan JH; Gu LQ; Huang ZS; Yin S; Li D
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1372-1382. PubMed ID: 28870734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.
    Cao D; Zhao J; Nguyan LN; Nguyen LNT; Khanal S; Dang X; Schank M; Chand Thakuri BK; Wu XY; Morrison ZD; El Gazzar M; Zou Y; Ning S; Wang L; Moorman JP; Yao ZQ
    Front Immunol; 2019; 10():1152. PubMed ID: 31191531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
    Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
    J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
    Moorman JP; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Thayer P; Islam TM; Borthwick T; Yao ZQ
    Vaccine; 2011 Apr; 29(17):3169-76. PubMed ID: 21376795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection.
    Yonkers NL; Sieg S; Rodriguez B; Anthony DD
    J Infect Dis; 2011 Mar; 203(5):635-45. PubMed ID: 21220773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
    Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
    Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.
    Shi L; Wang JM; Ren JP; Cheng YQ; Ying RS; Wu XY; Lin SM; Griffin JW; Li GY; Moorman JP; Yao ZQ
    J Immunol; 2014 Jan; 192(2):649-57. PubMed ID: 24337749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4
    Skardasi G; Chen AY; Michalak TI
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29167333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired thymic output in patients with chronic hepatitis C virus infection.
    Hartling HJ; Gaardbo JC; Ronit A; Salem M; Laye M; Clausen MR; Skogstrand K; Gerstoft J; Ullum H; Nielsen SD
    Scand J Immunol; 2013 Oct; 78(4):378-86. PubMed ID: 23841696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
    Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
    Xiao W; Jiang LF; Deng XZ; Zhu DY; Pei JP; Xu ML; Li BJ; Wang CJ; Zhang JH; Zhang Q; Zhou ZX; Ding WL; Xu XD; Yue M
    Immunol Res; 2016 Apr; 64(2):412-23. PubMed ID: 26286967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.